BISCHOFBERGER NORBERT W
SEC CIK 1190273 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | Dir | 21.3K | — | — | 5 | 2024-05-29 | 2026-05-27 |
Most active insiders at VIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| 3 | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| 4 | SATO VICKI L | Dir | — | $1.73M |
| 5 | De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| 6 | de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| 7 | Sabatini Brent | SVP, CAO | — | $113.1K |
| 8 | O'Byrne Jason | EVP, CFO | — | $68.9K |
| 9 | Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| 10 | Napolitano Janet | Dir | — | $30.2K |
| 16 | BISCHOFBERGER NORBERT W | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-28 19:23 | 2026-05-27 | VIR | Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +8,000 | 21.3K | +60% | $0 |
| I | 2025-06-06 | 2025-06-06 | VIR | Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | +10.7K | 10.7K | New | $0 |
| 2025-06-06 | 2025-06-06 | VIR | Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | -10.7K | 13.3K | -44% | $0 | |
| D | 2025-06-02 | 2025-05-30 | VIR | Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +8,000 | 24.0K | +50% | $0 |
| D | 2024-05-31 | 2024-05-29 | VIR | Vir Biotechnology, Inc. | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations